A web-based questionnaire survey on the influence of coronavirus disease-19 on the care of patients with muscular dystrophy

Tsuyoshi Matsumura,Hiroto Takada,Michio Kobayashi,Takashi Nakajima,Katsuhisa Ogata,Akinori Nakamura,Michinori Funato,Satoshi Kuru,Kiyonobu Komai,Naonobu Futamura,Yoshiki Adachi,Hajime Arahata,Takayasu Fukudome,Masatoshi Ishizaki,Shugo Suwazono,Masashi Aoki,Tohru Matsuura,Masanori P Takahashi,Yoshihide Sunada,Kouzou Hanayama,Hiroya Hashimoto,Harumasa Nakamura

DOI: https://doi.org/10.1016/j.nmd.2021.04.008

Abstract:To clarify the influence of coronavirus disease-19 (COVID-19) on the care of muscular dystrophy patients, we performed a questionnaire survey that was posted on the internet on May 11, 2020. By the end of July 2020, 542 responses had been collected. Approximately 30% of patients postponed regular consultations, and one-quarter of patients who received consultation more than once a month used telephone consultations. Two of 84 patients with Duchenne muscular dystrophy had reduced their steroid doses. A shortage of ventilator accessories and infection protection equipment occurred following the onset of COVID-19, and this shortage had a serious impact on medical care and infection prevention measures. Reductions in rehabilitation and other services, and avoidance of outings, led to a decrease in exercise and an increase in caregiver burden. Inpatients were restricted from going out and visiting family members. More than 20% of patients reported physical or mental complaints; however, few required treatment. COVID-19 has seriously affected the activities and quality of life of patients with muscular dystrophy. We will continue this survey and analyze the longitudinal changes.